Impact of socio-psychological factors on treatment adherence of TB patients in Russia

Tuberculosis

Volumn 88, Issue 5, 2008, Pages 495-502

  Jakubowiak, W M ^a   Bogorodskaya, E M ^b   Borisov, S E ^b   Danilova, I D ^a   Lomakina, O B ^c   Kourbatova, E V ^d  

^a WHO TB Control Programme in the Russian Federation   (Russian Federation)

^b I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

^c Moscow Research Institute of Psychiatry   (Russian Federation)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Behavior; Risk factors; Russia; Treatment adherence; Tuberculosis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; EMOTION; FEMALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL STAFF; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RISK ASSESSMENT; RUSSIAN FEDERATION; SOCIAL ASPECT; SOCIAL PSYCHOLOGY; TIME SERIES ANALYSIS; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; COUNSELING; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; QUESTIONNAIRES; RUSSIA; TUBERCULOSIS, PULMONARY;

EID: 49349095033     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2008.03.004     Document Type: Article

References (35)

1. Shilova M.V., and Dye C. The resurgence of tuberculosis in Russia. Philos Trans R Soc Lond B Biol Sci 356 1411 (2001) 1069-1075
2. Global tuberculosis control: surveillance, planning, financing. WHO report (2006), World Health Organization, Geneva (WHO/HTM/TB/2006.362)
3. Jakubowiak W.M., Bogorodskaya E.M., Borisov S.E., Danilova I.D., and Kourbatova E.V. Risk factors associated with default among new pulmonary TB patients and social support in six Russian regions. Int J Tuberc Lung Dis 11 1 (2007) 1-8
4. Centers for Disease Control and Prevention (CDC). Tuberculosis treatment interruptions - Ivanovo oblast, Russian Federation, 1999. MMWR Morb Mortal Wkly Rep 50 (2001) 201-204
5. Somova TR, Tsaplina LV, Volchenkov GV, Nemzova ES, Kazionny BY, Kiryanova EV, et al. Extensively drug-resistant (XDR) tuberculosis (TB) in Vladimir and Orel oblasts, Russia. Abstract Book 38th Union World Conference on Lung Health of the International Union Against Tuberculosis and Lung Disease. Cape Town, South Africa, 8-12 November 2007. S215. Abstract PS-71791-11.
6. Analytical review of the situation with tuberculosis in the Russian Federation, 2004: characteristics of epidemiological process and TB services (2006), Ministry of Health and Social Development of the Russian Federation, Central Research Institute of Public Health and IT, and Research Institute of Phthisiopulmonology of the Sechenov Moscow Medical Academy [in Russian]
7. Chaulet P. Compliance with chemotherapy for tuberculosis. Responsibilities of the Health Ministry and of physicians. Bull Int Union Tuberc Lung Dis 66 Suppl. (1990-1991) 33-35
8. Demissie M., and Kebede D. Defaulting from tuberculosis treatment at the Addis Abeba Tuberculosis Centre and factors associated with it. Ethiop Med J 32 2 (1994) 97-106
9. Bam T.S., Gunneberg C., Chamroonsawasdi K., Bam D.S., Aalberg O., Kasland O., et al. Factors affecting patient adherence to DOTS in urban Kathmandu, Nepal. Int J Tuberc Lung Dis 10 3 (2006) 270-276
10. Dodor E.A., and Afenyadu G.Y. Factors associated with tuberculosis treatment default and completion at the Effia-Nkwanta Regional Hospital in Ghana. Trans R Soc Trop Med Hyg 99 11 (2005) 827-832
11. Comolet T.M., Rakotomalala R., and Rajaonarioa H. Factors determining compliance with tuberculosis treatment in an urban environment, Tamatave, Madagascar. Int J Tuberc Lung Dis 2 11 (1998) 891-897
12. Mishra P., Hansen E.H., Sabroe S., and Kafle K.K. Adherence is associated with the quality of professional-patient interaction in directly observed treatment short-course, DOTS. Patient Educ Couns (2005)
13. Wares D.F., Singh S., Acharya A.K., and Dangi R. Non-adherence to tuberculosis treatment in the eastern Tarai of Nepal. Int J Tuberc Lung Dis 7 4 (2003) 327-335
14. Lertmaharit S., Kamol-Ratankul P., Sawert H., Jittimanee S., and Wangmanee S. Factors associated with compliance among tuberculosis patients in Thailand. J Med Assoc Thai 88 Suppl. 4 (2005) S149-S156
15. Prikaz (Order). On improvement of TB control activities in the Russian Federation (21 March 2003), Russia: Ministry of Health of the Russian Federation, Moscow (No 109). [in Russian]
16. World Health Organization. Revised international definitions in tuberculosis control. Int J Tuberc Lung Dis 5 3 (2001) 213-215
17. Prikaz (Order). On implementation of recording and reporting documentation for TB monitoring (13 February 2004), Russia: Ministry of Health of the Russian Federation, Moscow (No 50). [in Russian]
18. Burman W.J., Cohn D.L., Rietmeijer C.A., Judson F.N., Sbarbaro J.A., and Reves R.R. Noncompliance with directly observed therapy for tuberculosis. Epidemiology and effect on the outcome of treatment. Chest 111 5 (1997) 1168-1173
19. Davidson H., Schluger N.W., Feldman P.H., Valentine D.P., Telzak E.E., and Laufer F.N. The effects of increasing incentives on adherence to tuberculosis directly observed therapy. Int J Tuberc Lung Dis 4 9 (2000) 860-865
20. O'Boyle S.J., Power J.J., Ibrahim M.Y., and Watson J.P. Factors affecting patient compliance with anti-tuberculosis chemotherapy using the directly observed treatment, short-course strategy (DOTS). Int J Tuberc Lung Dis 6 4 (2002) 307-312
21. Santha T., Garg R., Frieden T.R., Chandrasekaran V., Subramani R., Gopi P.G., et al. Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000. Int J Tuberc Lung Dis 6 9 (2002) 780-788
22. Pablos-Mendez A., Knirsch C.A., Barr R.G., Lerner B.H., and Frieden T.R. Nonadherence in tuberculosis treatment: predictors and consequences in New York City. Am J Med 102 2 (1997) 164-170
23. Andreasen A.R. Marketing social change. Changing behavior to promote health, social development, and the environment. 1st ed. (1995), Jossey-Bass Publishers, San Francisco
24. Jakubowiak W.M., Bogorodskaya E.M., Borisov S.E., Danilova I.D., Lomakina O.B., and Kourbatova E.V. Social support and incentives program for patients with tuberculosis: experience from the Russian Federation. Int J Tuberc Lung Dis 11 11 (2007) 1-6
25. Fry R.S., Khoshnood K., and Vdovichenko E. Barriers to completion of tuberculosis treatment among prisoners and former prisoners in St. Petersburg, Russia. Int J Tuberc Lung Dis 9 9 (2005) 1027-1033
26. Atun R.A., Samyshkin Y.A., Drobniewski F., Skuratova N.M., Gusarova G., Kuznetsov S.I., et al. Barriers to sustainable tuberculosis control in the Russian Federation health system. Bull World Health Organ 83 3 (2005) 217-223
27. Dimitrova B., Balabanova D., Atun R., Drobniewski F., Levicheva V., and Coker R. Health service providers' perceptions of barriers to tuberculosis care in Russia. Health Policy Plan 21 4 (2006) 265-274
28. Jaiswal A., Singh V., Ogden J.A., Porter J.D., Sharma P.P., Sarin R., et al. Adherence to tuberculosis treatment: lessons from the urban setting of Delhi, India. Trop Med Int Health 8 7 (2003) 625-633
29. Peltzer K., Onya H., Seoka P., Tladi F.M., and Malema R.N. Factors at first diagnosis of tuberculosis associated with compliance with the directly observed therapy (DOT) in the Limpopo Province, South Africa. Curationis 25 3 (2002) 55-67
30. Fleming M.F., Krupitsky E., Tsoy M., Zvartau E., Brazhenko N., Jakubowiak W., et al. Alcohol and drug use disorders, HIV status and drug resistance in a sample of Russian TB patients. Int J Tuberc Lung Dis 10 5 (2006) 565-570
31. Beck A.T., and Steer R.A. Internal consistencies of the original and revised Beck Depression Inventory. J Clin Psychol 40 6 (1984) 1365-1367
32. Shin S.S., Pasechnikov A.D., Gelmanova I.Y., Peremitin G.G., Strelis A.K., Mishustin S., et al. Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia. Int J Tuberc Lung Dis 10 4 (2006) 402-408
33. Fleming M.F., Barry K.L., Manwell L.B., Johnson K., and London R. Brief physician advice for problem alcohol drinkers. A randomized controlled trial in community-based primary care practices. JAMA 277 13 (1997) 1039-1045
34. Bouza C., Angeles M., Munoz A., and Amate J.M. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review. Addiction 99 7 (2004) 811-828
35. Fleming M.F. Screening and brief intervention in primary care settings. Alcohol Res Health 28 2 (2004/2005) 57-62